BJ's Wholesale Club Holdings, Inc. ( BJ ) Q3 2026 Earnings Call November 21, 2025 8:30 AM EST Company Participants Anjaneya Singh Robert Eddy - President, CEO & Chairman Laura Felice - Executive VP & CFO William Werner - Executive Vice President of Strategy & Development Conference Call Participants Peter Benedict - Robert W. Baird & Co. Incorporated, Research Division Katharine McShane - Goldman Sachs Group, Inc., Research Division Robert Ohmes - BofA Securities, Research Division Steven Zaccone - Citigroup Inc., Research Division Michael Baker - D.A.

Jeremy Szafron joins Kitco News as an anchor and producer from Kitco's Vancouver bureau. Jeremy is a seasoned journalist with a diverse background covering entertainment, current affairs and finance.

ET currently trades below industry valuation, the vast pipeline network, fee-based revenues and expansion plans make it attractive, while lower ROE than industry is a concern.

XOM continues to increase dividends sustainably as upstream strength in Guyana and the Permian boosts earnings and cash flows.

LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.

Intellia sinks 67% in a month after a clinical hold on nex-z and mixed third-quarter results, raising questions about its pipeline outlook and near-term direction.

ADBE's $1.9B Semrush deal adds GEO and SEO tools to its AI-driven customer experience portfolio, aiming to boost ARR and customer brand visibility.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Primo Brands Corporation (“Primo” or “the Company”) (NYSE: PRMB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the publicly traded securities of Primo Water Corporation ("Primo Water") between June 17, 2024 through November 8, 2024, inclusive, and/or (the publicly traded common stock of Primo Brands Corporation between November 11, 2024 through November 6, …

Eli Lilly and Co (NYSE:LLY) briefly reached a market capitalization of $1 trillion during trading on Friday, making it the first healthcare company to achieve this milestone. Shares of the Indianapolis-based drugmaker rose as much as 1.7% just shy of $1,060, bringing its market value to roughly $1 trillion before retreating slightly, with stock trading near $1,050 per share later in the session.

Pearson PLC (LSE:PSON) may have had a soft quarter in Higher Education, but UBS thinks the real story is the acceleration of the market itself. After a flat Q3 last year, the analysts estimate US Higher Ed grew about 6% in Q3 2025, helped by a strong showing from McGraw Hill and steady progress at Cengage.

In today's market, investor attention remains fixated on a handful of mega-cap AI leaders driving the latest rally.

A $93 million US weapon sale to India puts the spotlight on defense stocks like LMT and, by extension, fuels momentum for defense ETFs like SHLD.

Novartis boosts long-term sales forecasts as blockbuster drugs like Kisqali and Scemblix drive strong momentum across its portfolio.

AstraZeneca secures FDA approval to expand Koselugo's use to treat adult NF1 patients with inoperable PN.

VinFast Auto Ltd. (VFS) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.25.

It's a proverbial tale of two retailers: the best of times for Walmart, the worst of times for Target. Both companies are preparing for leadership changes at the top, yet Walmart's incoming CEO has wind at his back, while Target's successor faces daunting challenges.

CVNA last traded at $313.25 a share after finding support at $285.02, which was double-bottom support dating back to June 2025.

A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.

Meta Platforms, Inc. stock is one of the best 12-month return opportunities on the market right now. The market's fear about AI capital expenditures and increased costs not correlating with direct return on investment is a buying opportunity for those who understand the long-term autonomy trajectory. I am targeting a 40% return in 12 months, and view this as a classic moment to buy amid herd hysteria.

Enviri Corporation ( NVRI ) M&A Call November 21, 2025 9:00 AM EST Company Participants David Martin - Director of Investor Relations F. Grasberger - Chairman, President & CEO Thomas Vadaketh - Senior VP & CFO Russell Hochman - Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Conference Call Participants Lawrence Solow - CJS Securities, Inc. Robert Brown - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good morning.